Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in Clinical Data

Kainova expands DT 7012 trial into Europe

 April 9, 2026

PharmaTimes

First patient dosed as DOMISOL study grows beyond Australia

Clinical DataOncologyRead full story

Post navigation

Roche sticks with C4T, adding up to $1B for molecular glue partnership →
← Innovent’s CDMO gets green light to make biologics at large Chinese plant

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com